Skip to main content
    S

    Stoke Therapeutics Inc (STOK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $26.41
    -0.22 (-0.83%)

    Market Cap: $1.74B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Stoke Therapeutics Inc (STOK) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Stoke Therapeutics (STOK) has a latest price of $26.41 on Nov 17, 2026, 34.3% below its 52-week high of $40.22. Its price fell 0.4% over the past 12 months. The month-end price rose 15.2% over the 5 years through Oct 2026, a compound annual rate of 2.9%.

    Price Chart

    From Jun 2019 to Oct 2026, its highest month-end close was $61.93 in Dec 2020 and its lowest $3.79 in Nov 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart STOK with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for STOK.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 20.0%, and over 6 months it fell 11.8%. The month-end price rose 590.0% over the 3 years through Oct 2026, a compound annual rate of 90.4%.

    PeriodChange
    1 month+6.4%
    3 months-20.0%
    6 months-11.8%
    12 months-0.4%
    12 months, with dividends-0.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+590.0%+90.4%
    5 years+15.2%+2.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 187.8%, and its weakest was 2022, when it fell 61.5%.

    YearCloseChange
    2026 through Oct 2026$26.29-17.2%
    2025$31.74+187.8%
    2024$11.03+109.7%
    2023$5.26-43.0%
    2022$9.23-61.5%
    2021$23.99-61.3%
    2020$61.93+118.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 0.4% above its 50-day average of $26.32 and 14.1% below its 200-day average of $30.75.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$26.41
    52-week high$40.22-34.3%
    52-week low$22.05+19.8%
    50-day average$26.32+0.4%
    200-day average$30.75-14.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 66.3%.

    MeasureValue
    1-year beta1.00
    Largest fall, 1 year-41.3%
    Largest fall, 3 years-66.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About STOK

    What is STOK's 1-year price change?

    Stoke Therapeutics's price fell 0.4% over the past 12 months. With dividends included, the 12-month total return was -0.4%.

    What is STOK's 5-year price change?

    Stoke Therapeutics's month-end price rose 15.2% over the 5 years through Oct 2026, a compound annual rate of 2.9%. These figures leave out dividends.

    What is STOK's 52-week high and low?

    Stoke Therapeutics's 52-week high is $40.22 and its 52-week low is $22.05. Its latest price of $26.41 on Nov 17, 2026 is 34.3% below the high.

    What is STOK's beta?

    Stoke Therapeutics's 1-year beta against the S&P 500 is 1.00, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 41.3%.

    Is the STOK chart free?

    Yes. Advanced Charting for STOK is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.